Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR)

NCT06234345 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

1252

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Fluticasone 250mcg/Formoterol 12mcg/Glycopyrronium 25mcg
DRUG: Comparator - Trimbow®

Sponsor

Eurofarma Laboratorios S.A.